Allarity Therapeutics, Inc. Investment Income, Interest
Allarity Therapeutics, Inc. (ALLR) reported Investment Income, Interest of $217.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- Allarity Therapeutics, Inc. investment income, interest for the quarter ending 2026-06-30 was $217.00K, a 8.44% decline year-over-year.
- Allarity Therapeutics, Inc. investment income, interest for the quarter ending 2026-03-31 was $163.00K, a 26.58% decline year-over-year.
- Allarity Therapeutics, Inc. investment income, interest for the quarter ending 2025-12-31 was $155.00K, a 29.22% decline year-over-year.
- Allarity Therapeutics, Inc. investment income, interest for the quarter ending 2025-09-30 was $187.00K, a 28.35% decline year-over-year.
- Allarity Therapeutics, Inc. investment income, interest for fiscal 2025 was $801.00K, a 50.28% increase from fiscal 2024.
- Allarity Therapeutics, Inc. investment income, interest for fiscal 2024 was $533.00K, a 2322.73% increase from fiscal 2023.
- Allarity Therapeutics, Inc. investment income, interest for fiscal 2023 was $22.00K, a 26.67% decline from fiscal 2022.
- Allarity Therapeutics, Inc. investment income, interest for fiscal 2022 was $30.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $217.00K 10-Q · filed 2026-08-14 | $380.00K 10-Q · filed 2026-08-14 | $535.00K derived: sum of 3 quarters · filed 2026-08-14 | $722.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $163.00K 10-Q · filed 2026-05-15 | $318.00K derived: sum of 2 quarters · filed 2026-05-15 | $505.00K derived: sum of 3 quarters · filed 2026-05-15 | $742.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $342.00K derived: sum of 2 quarters · filed 2026-03-30 | $579.00K derived: sum of 3 quarters · filed 2026-08-14 | $801.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $187.00K 10-Q · filed 2025-11-14 | $424.00K derived: sum of 2 quarters · filed 2026-08-14 | $646.00K 10-Q · filed 2025-11-14 | $865.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $237.00K 10-Q · filed 2026-08-14 | $459.00K 10-Q · filed 2026-08-14 | $678.00K derived: sum of 3 quarters · filed 2026-08-14 | $939.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $222.00K 10-Q · filed 2026-05-15 | $441.00K derived: sum of 2 quarters · filed 2026-05-15 | $702.00K derived: sum of 3 quarters · filed 2026-05-15 | $755.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $480.00K derived: sum of 2 quarters · filed 2026-03-30 | $533.00K derived: sum of 3 quarters · filed 2026-03-30 | $533.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $261.00K 10-Q · filed 2025-11-14 | $314.00K derived: sum of 2 quarters · filed 2025-11-14 | $314.00K 10-Q · filed 2025-11-14 | $317.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $53.00K 10-Q · filed 2025-08-15 | $53.00K 10-Q · filed 2025-08-15 | $56.00K derived: sum of 3 quarters · filed 2025-08-15 | $68.00K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $3.00K derived: sum of 2 quarters · filed 2025-05-09 | $15.00K derived: sum of 3 quarters · filed 2025-05-09 | $18.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $15.00K derived: sum of 2 quarters · filed 2025-03-31 | $18.00K derived: sum of 3 quarters · filed 2025-03-31 | $22.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $12.00K 10-Q · filed 2024-11-14 | $15.00K derived: sum of 2 quarters · filed 2024-11-14 | $19.00K 10-Q · filed 2024-11-14 | $30.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-05 | $7.00K 10-Q · filed 2024-08-05 | $18.00K derived: sum of 3 quarters · filed 2024-08-05 | $32.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-14 | $15.00K derived: sum of 2 quarters · filed 2024-05-14 | $29.00K derived: sum of 3 quarters · filed 2024-05-14 | $34.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $25.00K derived: sum of 2 quarters · filed 2024-03-08 | $30.00K derived: sum of 3 quarters · filed 2024-03-08 | $30.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $14.00K 10-Q · filed 2023-11-14 | $19.00K derived: sum of 2 quarters · filed 2023-11-14 | $19.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $5.00K 10-Q · filed 2023-08-14 | $5.00K 10-Q · filed 2023-08-14 | ||
| 2021-09-30 | $28.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |